TB Evenlode Income B Income
UK Equity Income
Rated Fund 2015-2018. Complement to deep value funds
TB Evenlode Income won Money Observer's Best Larger UK Equity Income Fund award in 2016 — a crown it retained last year.Its yield is 3.2 per cent and income is paid quarterly. Its manager Hugh Yarrow and co-manager Ben Peters pursue a distinctive approach. They look to buy companies that are able to grow sustainably without needing to reinvest much capital back into the business each year to generate growth. Their rationale is that these companies will have more cash available to pay to shareholders.For income-seekers looking to achieve diversity, their approach acts as a good complement to funds that focus on deep value and higher-yielding companies.Investing in asset-light, high-return businesses results in a portfolio that is quite different from the UK market, which means the fund will be out of step with market trends at times. One of the reasons is that this focus causes the managers to avoid some large sectors, such as banks and oil producers or miners.It has a minimum of 80 per cent in UK shares with the balance in overseas shares or cash, and has performed particularly well since the Brexit referendum, given its allocation to larger, dollar-earning companies. There are less than 40 holdings in the portfolio, but the managers contend that they believe in quality over quantity.
The fund was forced to move from the Investment Association's UK equity income sector into the UK all companies sector on account of an insufficient yield. It could have returned to its former sector last year, but the managers opted not to as they did not want to be constrained by the sector's yield requirements.
Narrative and ratings content all as of 01 January 2018.See all Money Observer rated funds
|Unilever PLC||8.41 %|
|Diageo PLC||7.65 %|
|RELX PLC||5.72 %|
|Compass Group PLC||5.41 %|
|Sage Group (The) PLC||4.62 %|
|Reckitt Benckiser Group PLC||4.55 %|
|GlaxoSmithKline PLC||4.14 %|
|Smiths Group PLC||3.89 %|
|Smith & Nephew PLC||3.67 %|
|AstraZeneca PLC||3.19 %|
|United Kingdom||83.86 %|
|United States||12.23 %|
|Consumer Defensive||27.46 %|
|Consumer Cyclical||24.35 %|
Hugh joined Wise in 2009 and is the lead portfolio manager of Evenlode Income, the UK Equity Income fund he launched in October of the same year. He was appointed as a director of Wise in 2012. Hugh graduated from the University of Edinburgh with a first class degree in philosophy and mathematics in 2002. From 2002 to 2009 he worked as an investment manager on several equity income funds at Rathbone Unit Trust Management. Hugh is a Chartered Fellow of the Chartered Institute for Securities & Investment and holds the Investment Management Certificate.
Ben is a member of the CFA Society of the UK and holds the Investment Management Certificate. He also holds a doctorate from the University of Oxford in the field of physics.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.